Tag: post-marketing pharmacovigilance and medical information market growth

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Post-Marketing Pharmacovigilance And Medical Information Market Growth Potential: How Will Market Size Shift Through 2030?#_x000D_

The post-marketing pharmacovigilance and medical information market has observed rapid expansion in recent years. It will grow from $6.9 billion in 2025 to $7.71 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The market’s historical growth can be linked to factors like a constrained post-marketing surveillance infrastructure, reliance on manual adverse drug reaction reporting, increasing regulatory mandates for drug safety, a rise in new drug approvals, and the absence of integrated hospital data systems._x000D_

_x000D_

The post-marketing pharmacovigilance and medical information market is projected to experience substantial expansion in the coming years. This market is set to reach $11.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this growth over the forecast period include the incorporation of AI and ML algorithms in signal detection, the increasing use of longitudinal patient data analysis, the expansion of monitoring linked to disease registries, a rise in digital app-based reporting, and greater investments in real-time pharmacovigilance technologies. Key trends anticipated during the forecast period involve the growing acceptance of electronic health record (EHR) mining, increased deployment of real-time adverse drug reaction (ADR) monitoring systems, a surge in reporting based on risk populations and therapeutic classes, the expansion of cohort event monitoring for new drug users, and the integration of digital and mobile platforms for pharmacovigilance reporting._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=62415193&type=smp&name=Post-Marketing%20Pharmacovigilance%20And%20Medical%20Information%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Post-Marketing Pharmacovigilance And Medical Information Market Growth Factors: What’s Supporting Expansion?#_x000D_

The expansion of the post-marketing pharmacovigilance and medical information market is anticipated to be driven by the growing occurrence of adverse drug reactions. These reactions are defined as undesirable or detrimental effects that arise when a medication is administered at its prescribed dosage for purposes such as prevention, diagnosis, or treatment. The frequency of adverse drug reactions is increasing due to the aging demographic’s rising need for managing multiple chronic health conditions. This often involves taking several medications concurrently, which escalates the potential for harmful drug interactions and unforeseen side effects. The post-marketing pharmacovigilance and medical information sector plays a crucial role in addressing adverse drug reactions by identifying, monitoring, and disseminating information about potential side effects once a drug has been released to the market, thereby helping to preserve its safety and efficacy. For example, data from January 2023, reported by Navikenz, a US-based IT services firm specializing in artificial intelligence, indicates that in the US, adverse drug reactions are estimated to be responsible for 200,000 to 400,000 deaths annually. This figure surpasses the combined fatalities from stroke and diabetes, with approximately 2.7 million cases occurring each year, leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the escalating incidence of adverse drug reactions is fueling the development of the post-marketing pharmacovigilance and medical information market._x000D_

_x000D_

#Post-Marketing Pharmacovigilance And Medical Information Market Segments: Where Is Growth Concentrated?#_x000D_

The post-marketing pharmacovigilance and medical information market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining_x000D_

2) By Publication Type: Books, Online Media, Journals_x000D_

3) By End User: Hospitals, Research Organizations, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting_x000D_

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems_x000D_

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting_x000D_

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring_x000D_

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems_x000D_

_x000D_

#Post-Marketing Pharmacovigilance And Medical Information Market Industry Trends: What’s Reshaping Demand?#_x000D_

Leading companies in the post-marketing pharmacovigilance and medical information market are focusing on developing sophisticated solutions, such as AI-driven pharmacovigilance workflows, to enhance the precision of adverse event detection and enable real-time safety oversight for improved patient outcomes. These AI-powered pharmacovigilance workflows utilize artificial intelligence to automate drug safety monitoring, facilitating quicker adverse event identification and improved adherence to regulations. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, unveiled a centralized Summary of Product Characteristics (SmPC) management system for life science companies and research organizations. This platform consolidates essential drug safety information into a single, easily accessible repository, automates literature surveillance and regulatory submissions, improves team collaboration, and optimizes compliance processes through advanced AI functionalities. This allows pharmacovigilance teams to operate with greater efficiency and proactivity, ensuring both patient well-being and conformity to regulatory standards._x000D_

_x000D_

#Post-Marketing Pharmacovigilance And Medical Information Market Key Participants And Competitive Landscape#_x000D_

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC _x000D_

_x000D_

#View The Full Post-Marketing Pharmacovigilance And Medical Information Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Post-Marketing Pharmacovigilance And Medical Information Market Largest Region: Which Geography Holds The Highest Market Share?#_x000D_

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Post-Marketing Pharmacovigilance And Medical Information Market Expansion From $7.71 Billion In 2026 To $11.89 Billion In 2030

The market for post-marketing pharmacovigilance and medical information has experienced swift expansion in recent times. Valued at $6.9 billion in 2025, it is projected to reach $7.71 billion by 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. Factors driving growth during the historical period include insufficient post-marketing surveillance infrastructure, dependence on manual adverse drug reaction (ADR) reporting, escalating regulatory demands for drug safety, a rising volume of new drug approvals, and the absence of integrated hospital data systems.

The market for post-marketing pharmacovigilance and medical information is projected to undergo rapid expansion over the coming years, reaching an estimated value of $11.89 billion by 2030, which corresponds to a compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period is driven by several key factors, including the integration of artificial intelligence and machine learning algorithms into signal detection, the adoption of longitudinal patient data analysis, the expansion of monitoring linked to disease registries, an increase in digital app-based reporting, and heightened investments in real-time pharmacovigilance technologies. Prominent trends shaping this period encompass the growing adoption of electronic health record (EHR) mining, a rise in the use of real-time adverse drug reaction (ADR) monitoring systems, an expansion of reporting based on risk populations and therapeutic classes, the broadening of cohort event monitoring for users of new drugs, as well as the integration of digital and mobile platforms for pharmacovigilance reporting.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Post-Marketing Pharmacovigilance And Medical Information Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing frequency of adverse drug reactions is anticipated to boost the expansion of the post-marketing pharmacovigilance and medical information market moving forward. Adverse drug reactions involve detrimental or unintended effects arising from medication use at prescribed doses for prevention, diagnosis, or treatment. This rise is driven by the growing elderly population requiring management of multiple chronic conditions, which often involves concurrent use of various drugs, thereby elevating the risk of harmful interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information aid in addressing these reactions by identifying, monitoring, and disseminating data on potential side effects after a drug’s release, ensuring its ongoing safety and efficacy. As an example, in January 2023, Navikenz, a US-based AI-focused IT services firm, reported that adverse drug reactions cause an estimated 200,000 to 400,000 fatalities annually in the United States, surpassing the combined death toll from stroke and diabetes, with about 2.7 million cases each year leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the rising prevalence of adverse drug reactions is fueling the growth of the post-marketing pharmacovigilance and medical information market.

Post-Marketing Pharmacovigilance And Medical Information Market Segment Landscape: Which Areas Lead Market Development?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Post-Marketing Pharmacovigilance And Medical Information Market Trends Reshaping Industry Growth

Major players in the post-marketing pharmacovigilance and medical information market are concentrating on creating sophisticated tools, including AI-enhanced pharmacovigilance workflows, to improve the precision of adverse event detection and facilitate real-time safety surveillance for superior patient results. These AI-powered workflows leverage artificial intelligence to automate drug safety surveillance, allowing for quicker identification of adverse events and strengthened regulatory adherence. As an example, in January 2024, PubHive Ltd., a UK-based provider of cloud-based software-as-a-service (SaaS) solutions, unveiled a centralized Summary of Product Characteristics (SmPC) management system designed for life science firms and research entities. This system gathers vital drug safety data into a single, easily navigable repository, automates literature tracking and regulatory submissions, boosts team collaboration, and simplifies compliance tasks using advanced AI features. Consequently, pharmacovigilance teams can function with greater efficiency and foresight, upholding patient safety while meeting regulatory requirements.

Post-Marketing Pharmacovigilance And Medical Information Market Industry Leaders And Market Competition

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Access The Complete Post-Marketing Pharmacovigilance And Medical Information Market Report:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Post-Marketing Pharmacovigilance And Medical Information Market Largest Region By Revenue And Market Share

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Post-Marketing Pharmacovigilance And Medical Information Market By 2030?

The market size for post-marketing pharmacovigilance and medical information has expanded rapidly in recent years. It is anticipated to grow from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical growth can be attributed to elements such as limited post-marketing surveillance infrastructure, reliance on manual ADR reporting, increasing regulatory requirements for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.

The post-marketing pharmacovigilance and medical information market size is anticipated to undergo rapid expansion in the coming years. It is projected to reach $11.89 billion in 2030, at a compound annual growth rate (CAGR) of 11.4%. This growth during the forecast period can be attributed to the integration of AI and ML algorithms into signal detection, the adoption of longitudinal patient data analysis, the broadening of disease registry-linked monitoring, an increase in digital app-based reporting, and rising investments in real-time pharmacovigilance technologies. Key trends for the forecast period include the increasing embrace of electronic health record (EHR) mining, a growing utilization of real-time adverse drug reaction (ADR) monitoring systems, an expansion in risk population-based and therapeutic class-based reporting, the extension of cohort event monitoring for new drug users, and the incorporation of digital and mobile platforms for pharmacovigilance reporting.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Core Drivers Are Transforming The Post-Marketing Pharmacovigilance And Medical Information Market?

An increasing occurrence of adverse drug reactions is projected to drive expansion in the post-marketing pharmacovigilance and medical information market. These reactions are defined as undesirable or detrimental effects that manifest when a drug is administered at its prescribed dose for preventive, diagnostic, or therapeutic reasons. The frequency of adverse drug reactions is escalating because the elderly demographic increasingly needs remedies for various long-term illnesses, resulting in the concurrent use of multiple drugs, which elevates the potential for detrimental interactions and unforeseen adverse events. The post-marketing pharmacovigilance and medical information sector aids in managing adverse drug reactions through identifying, monitoring, and disseminating information about potential side effects once a drug has been introduced to the market, thereby assisting in preserving its safety and efficacy. As an illustration, data from January 2023, provided by Navikenz, a US-based IT services firm specializing in artificial intelligence, indicates that in the US, adverse drug reactions are approximated to lead to 200,000 to 400,000 fatalities each year, surpassing the combined mortality from stroke and diabetes. Annually, approximately 2.7 million cases lead to more than 100,000 hospitalizations and over 15,000 deaths. Consequently, the increased occurrence of adverse drug reactions is a primary factor fueling the expansion of the post-marketing pharmacovigilance and medical information market.

Which Segment-Based Categories Are Covered In The Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Trends Are Influencing The Direction Of The Post-Marketing Pharmacovigilance And Medical Information Market?

Leading companies in the post-marketing pharmacovigilance and medical information market are focusing on developing advanced solutions, such as AI-driven pharmacovigilance processes, to improve the accuracy of adverse event detection and enable real-time safety monitoring for enhanced patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, leading to faster identification of adverse events and improved regulatory adherence. For instance, in January 2024, PubHive Ltd., a UK-based cloud-software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management system for life science companies and research organizations. This platform consolidates vital drug safety information into a single, easily accessible repository, automates literature surveillance and regulatory reporting, strengthens team collaboration, and streamlines compliance procedures through advanced AI capabilities. This empowers pharmacovigilance teams to operate more efficiently and proactively, ensuring both patient safety and conformity to regulatory standards.

Which Organizations Are Operating Within The Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Access The Complete Post-Marketing Pharmacovigilance And Medical Information Market Report:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Regional Market Leads The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Post-Marketing Pharmacovigilance And Medical Information Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Post-Marketing Pharmacovigilance And Medical Information Market Grow Between 2026 And 2030?

The market for post-marketing pharmacovigilance and medical information has experienced rapid expansion recently. It is projected to increase from $6.9 billion in 2025 to $7.71 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be linked to factors such as inadequate post-marketing surveillance systems, dependence on manual adverse drug reaction (ADR) submissions, evolving regulatory demands for drug safety, a rise in new drug authorizations, and the absence of unified hospital data platforms.

The post-marketing pharmacovigilance and medical information market is projected for significant expansion in the coming years. Its value is anticipated to reach $11.89 billion by 2030, advancing at a compound annual growth rate (CAGR) of 11.4%. This anticipated growth is driven by factors such as the incorporation of AI and ML algorithms for signal detection, the utilization of longitudinal patient data analysis, the broader scope of disease registry-linked surveillance, a surge in digital application-based reporting, and increased funding for real-time pharmacovigilance solutions. Key developments foreseen during this period encompass the growing uptake of electronic health record (EHR) data mining, the wider implementation of real-time adverse drug reaction (ADR) monitoring systems, an increase in reporting tailored to specific risk populations and therapeutic classes, the extension of cohort event monitoring for novel drug users, and the unification of digital and mobile platforms for pharmacovigilance reporting.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Key Factors Are Shaping The Post-Marketing Pharmacovigilance And Medical Information Market Landscape?

The increasing occurrence of adverse drug reactions is anticipated to fuel the expansion of the post-marketing pharmacovigilance and medical information market moving forward. Adverse drug reactions are defined as undesirable or damaging effects that manifest when a medicine is administered at its recommended dosage for the purpose of prevention, diagnosis, or treatment. The frequency of adverse drug reactions is escalating as the aging demographic increasingly requires treatment for numerous chronic conditions, leading to the simultaneous use of several medications, which heightens the probability of harmful drug interactions and unexpected side effects. Post-marketing pharmacovigilance and medical information aid in managing adverse drug reactions by identifying, tracking, and sharing information on potential side effects after a medicine has been launched, thereby helping to maintain its safety and effectiveness. For instance, in January 2023, according to Navikenz, a US-based artificial intelligence-focused IT services company, in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, surpassing the combined fatalities from stroke and diabetes, with approximately 2.7 million cases each year resulting in over 100,000 hospitalizations and more than 15,000 deaths. Thus, the escalating incidence of adverse drug reactions is driving the growth of the post-marketing pharmacovigilance and medical information market.

How Is The Post-Marketing Pharmacovigilance And Medical Information Market Broken Down By Segment Categories?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

What Trends Are Influencing The Post-Marketing Pharmacovigilance And Medical Information Market?

Leading companies within the post-marketing pharmacovigilance and medical information market are prioritizing the development of advanced solutions, such as AI-powered pharmacovigilance workflows, to improve the accuracy of adverse event detection and enable real-time safety monitoring, ultimately leading to better patient outcomes. These AI-powered pharmacovigilance workflows utilize artificial intelligence to automate drug safety surveillance, facilitating quicker adverse event identification and enhancing regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management system for life science companies and research organizations. This platform consolidates essential drug safety information into a single, readily available repository, automates literature monitoring and regulatory reporting, strengthens team collaboration, and streamlines compliance processes through sophisticated AI capabilities. This empowers pharmacovigilance teams to operate with increased efficiency and proactivity, ensuring both patient safety and adherence to regulatory standards.

Which Players Are Present In The Post-Marketing Pharmacovigilance And Medical Information Market Space?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Get The Full Post-Marketing Pharmacovigilance And Medical Information Market Report:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Region Holds The Highest Market Share In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Post-Marketing Pharmacovigilance And Medical Information Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Post-Marketing Pharmacovigilance And Medical Information Market Between 2026 And 2030?

The post-marketing pharmacovigilance and medical information market has expanded rapidly in recent years. This market is expected to grow from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The expansion observed in the past can be attributed to reasons such as limited post-marketing surveillance infrastructure, reliance on manual ADR reporting, increasing regulatory requirements for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.

The post-marketing pharmacovigilance and medical information market is projected for substantial expansion over the coming years. Its valuation is anticipated to reach $11.89 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period is propelled by factors such as the integration of AI and ML algorithms for enhanced signal detection, the broader adoption of longitudinal patient data analysis, the expansion of disease registry-linked monitoring, the surge in digital app-based reporting, and increased investments in real-time pharmacovigilance technologies. Furthermore, significant trends expected over this period encompass a growing adoption of electronic health record (EHR) mining, an increasing deployment of real-time adverse drug reaction (ADR) monitoring systems, a rise in reporting categorized by risk population and therapeutic class, the broadening of cohort event monitoring for new drug users, and the seamless integration of digital and mobile platforms for pharmacovigilance reporting.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Major Drivers Are Influencing Demand In The Post-Marketing Pharmacovigilance And Medical Information Market?

The increasing occurrence of adverse drug reactions is anticipated to fuel the expansion of the post-marketing pharmacovigilance and medical information market in the future. These reactions are defined as detrimental or unforeseen effects arising from medication use at prescribed dosages for purposes such as prevention, diagnosis, or treatment. The frequency of adverse drug reactions is escalating because the elderly population increasingly needs to manage numerous chronic illnesses, which often involves taking multiple drugs concurrently, thereby increasing the risk of detrimental drug interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information services aid in handling adverse drug reactions through identifying, monitoring, and disseminating information about potential side effects once a drug is on the market, thus contributing to its continued safety and efficacy. For example, in January 2023, data from Navikenz, a US-based artificial intelligence-focused IT services company, indicated that adverse drug reactions in the US are projected to be responsible for 200,000 to 400,000 deaths annually, surpassing the combined fatalities from stroke and diabetes, with approximately 2.7 million annual cases leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the growing occurrence of adverse drug reactions is propelling the expansion of the post-marketing pharmacovigilance and medical information market.

Which Market Segments Are Examined In The Post-Marketing Pharmacovigilance And Medical Information Market Study?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Trends Are Influencing The Post-Marketing Pharmacovigilance And Medical Information Market?

Companies operating within the post-marketing pharmacovigilance and medical information market are prioritizing the development of advanced solutions, such as AI-powered pharmacovigilance workflows, to bolster the accuracy of adverse event detection and enable real-time safety monitoring for improved patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, thereby allowing for faster adverse event identification and enhanced regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management solution for life science companies and research organizations. This platform consolidates crucial drug safety information into a unified, easily accessible repository, automates literature monitoring and regulatory reporting, strengthens team collaboration, and simplifies compliance processes through advanced AI capabilities. This empowers pharmacovigilance teams to function more efficiently and proactively, ensuring both patient safety and adherence to regulatory standards.

Who Are The Primary Competitors In The Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Read the full post-marketing pharmacovigilance and medical information market report here:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Post-Marketing Pharmacovigilance And Medical Information Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Post-Marketing Pharmacovigilance And Medical Information Market Between 2026 And 2030?

The post-marketing pharmacovigilance and medical information market has expanded rapidly in recent years. This market is expected to grow from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The expansion observed in the past can be attributed to reasons such as limited post-marketing surveillance infrastructure, reliance on manual ADR reporting, increasing regulatory requirements for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.

The post-marketing pharmacovigilance and medical information market is projected for substantial expansion over the coming years. Its valuation is anticipated to reach $11.89 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period is propelled by factors such as the integration of AI and ML algorithms for enhanced signal detection, the broader adoption of longitudinal patient data analysis, the expansion of disease registry-linked monitoring, the surge in digital app-based reporting, and increased investments in real-time pharmacovigilance technologies. Furthermore, significant trends expected over this period encompass a growing adoption of electronic health record (EHR) mining, an increasing deployment of real-time adverse drug reaction (ADR) monitoring systems, a rise in reporting categorized by risk population and therapeutic class, the broadening of cohort event monitoring for new drug users, and the seamless integration of digital and mobile platforms for pharmacovigilance reporting.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Major Drivers Are Influencing Demand In The Post-Marketing Pharmacovigilance And Medical Information Market?

The increasing occurrence of adverse drug reactions is anticipated to fuel the expansion of the post-marketing pharmacovigilance and medical information market in the future. These reactions are defined as detrimental or unforeseen effects arising from medication use at prescribed dosages for purposes such as prevention, diagnosis, or treatment. The frequency of adverse drug reactions is escalating because the elderly population increasingly needs to manage numerous chronic illnesses, which often involves taking multiple drugs concurrently, thereby increasing the risk of detrimental drug interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information services aid in handling adverse drug reactions through identifying, monitoring, and disseminating information about potential side effects once a drug is on the market, thus contributing to its continued safety and efficacy. For example, in January 2023, data from Navikenz, a US-based artificial intelligence-focused IT services company, indicated that adverse drug reactions in the US are projected to be responsible for 200,000 to 400,000 deaths annually, surpassing the combined fatalities from stroke and diabetes, with approximately 2.7 million annual cases leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the growing occurrence of adverse drug reactions is propelling the expansion of the post-marketing pharmacovigilance and medical information market.

Which Market Segments Are Examined In The Post-Marketing Pharmacovigilance And Medical Information Market Study?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Trends Are Influencing The Post-Marketing Pharmacovigilance And Medical Information Market?

Companies operating within the post-marketing pharmacovigilance and medical information market are prioritizing the development of advanced solutions, such as AI-powered pharmacovigilance workflows, to bolster the accuracy of adverse event detection and enable real-time safety monitoring for improved patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, thereby allowing for faster adverse event identification and enhanced regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management solution for life science companies and research organizations. This platform consolidates crucial drug safety information into a unified, easily accessible repository, automates literature monitoring and regulatory reporting, strengthens team collaboration, and simplifies compliance processes through advanced AI capabilities. This empowers pharmacovigilance teams to function more efficiently and proactively, ensuring both patient safety and adherence to regulatory standards.

Who Are The Primary Competitors In The Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Read the full post-marketing pharmacovigilance and medical information market report here:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Post-Marketing Pharmacovigilance And Medical Information Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Post-Marketing Pharmacovigilance And Medical Information Market Between 2026 And 2030?

The post-marketing pharmacovigilance and medical information market has expanded rapidly in recent years. This market is expected to grow from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The expansion observed in the past can be attributed to reasons such as limited post-marketing surveillance infrastructure, reliance on manual ADR reporting, increasing regulatory requirements for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.

The post-marketing pharmacovigilance and medical information market is projected for substantial expansion over the coming years. Its valuation is anticipated to reach $11.89 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period is propelled by factors such as the integration of AI and ML algorithms for enhanced signal detection, the broader adoption of longitudinal patient data analysis, the expansion of disease registry-linked monitoring, the surge in digital app-based reporting, and increased investments in real-time pharmacovigilance technologies. Furthermore, significant trends expected over this period encompass a growing adoption of electronic health record (EHR) mining, an increasing deployment of real-time adverse drug reaction (ADR) monitoring systems, a rise in reporting categorized by risk population and therapeutic class, the broadening of cohort event monitoring for new drug users, and the seamless integration of digital and mobile platforms for pharmacovigilance reporting.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Major Drivers Are Influencing Demand In The Post-Marketing Pharmacovigilance And Medical Information Market?

The increasing occurrence of adverse drug reactions is anticipated to fuel the expansion of the post-marketing pharmacovigilance and medical information market in the future. These reactions are defined as detrimental or unforeseen effects arising from medication use at prescribed dosages for purposes such as prevention, diagnosis, or treatment. The frequency of adverse drug reactions is escalating because the elderly population increasingly needs to manage numerous chronic illnesses, which often involves taking multiple drugs concurrently, thereby increasing the risk of detrimental drug interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information services aid in handling adverse drug reactions through identifying, monitoring, and disseminating information about potential side effects once a drug is on the market, thus contributing to its continued safety and efficacy. For example, in January 2023, data from Navikenz, a US-based artificial intelligence-focused IT services company, indicated that adverse drug reactions in the US are projected to be responsible for 200,000 to 400,000 deaths annually, surpassing the combined fatalities from stroke and diabetes, with approximately 2.7 million annual cases leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the growing occurrence of adverse drug reactions is propelling the expansion of the post-marketing pharmacovigilance and medical information market.

Which Market Segments Are Examined In The Post-Marketing Pharmacovigilance And Medical Information Market Study?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Trends Are Influencing The Post-Marketing Pharmacovigilance And Medical Information Market?

Companies operating within the post-marketing pharmacovigilance and medical information market are prioritizing the development of advanced solutions, such as AI-powered pharmacovigilance workflows, to bolster the accuracy of adverse event detection and enable real-time safety monitoring for improved patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, thereby allowing for faster adverse event identification and enhanced regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management solution for life science companies and research organizations. This platform consolidates crucial drug safety information into a unified, easily accessible repository, automates literature monitoring and regulatory reporting, strengthens team collaboration, and simplifies compliance processes through advanced AI capabilities. This empowers pharmacovigilance teams to function more efficiently and proactively, ensuring both patient safety and adherence to regulatory standards.

Who Are The Primary Competitors In The Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Read the full post-marketing pharmacovigilance and medical information market report here:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Post-Marketing Pharmacovigilance And Medical Information Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the post-marketing pharmacovigilance and medical information market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market size has experienced rapid growth in recent years. This market is set to expand from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this growth has been influenced by factors including limited post-marketing surveillance infrastructure, a reliance on manual adverse drug reaction (ADR) reporting, increasing regulatory mandates for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.

The post-marketing pharmacovigilance and medical information market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $11.89 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. This projected growth can be ascribed to several factors, including the incorporation of AI and ML algorithms in signal detection, the uptake of longitudinal patient data analysis, the broadening of disease registry-linked monitoring, the rise in digital application-based reporting, and increased investments in real-time pharmacovigilance technologies. Key trends anticipated during this period encompass the growing embrace of electronic health record (EHR) mining, the escalating utilization of real-time adverse drug reaction (ADR) monitoring systems, an increase in reporting based on risk populations and therapeutic classes, the expansion of cohort event monitoring for new drug users, and the integration of digital and mobile platforms for pharmacovigilance reporting.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Drivers Are Supporting Technological Adoption In The Post-Marketing Pharmacovigilance And Medical Information Market?

The increasing occurrence of adverse drug reactions is projected to propel the expansion of the post-marketing pharmacovigilance and medical information market in the future. Adverse drug reactions are defined as detrimental or unforeseen effects that appear when a drug is administered at its recommended dosage for preventive, diagnostic, or therapeutic objectives. The frequency of these reactions is escalating because the aging population increasingly requires interventions for numerous chronic conditions, leading to the simultaneous use of various medications which heightens the potential for dangerous drug interactions and unanticipated side effects. Post-marketing pharmacovigilance and medical information assist in managing adverse drug reactions by identifying, monitoring, and disseminating details on possible side effects once a medication is introduced to the market, thereby helping to maintain its ongoing safety and effectiveness. For instance, in January 2023, according to Navikenz, a US-based artificial intelligence-focused IT services company, in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, exceeding the combined mortality from stroke and diabetes, with approximately 2.7 million annual cases resulting in over 100,000 hospitalizations and more than 15,000 fatalities. Consequently, the escalating incidence of adverse drug reactions is driving the growth of the post-marketing pharmacovigilance and medical information market.

What Segment Types Are Examined In The Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Trends Are Guiding The Evolution Of The Post-Marketing Pharmacovigilance And Medical Information Market?

Leading businesses within the post-marketing pharmacovigilance and medical information market are concentrating their efforts on creating sophisticated tools, including AI-driven pharmacovigilance processes. This endeavor seeks to boost the precision of adverse event identification and facilitate continuous safety oversight, ultimately improving patient well-being. These AI-enhanced pharmacovigilance workflows leverage artificial intelligence to automate the surveillance of drug safety, thereby accelerating the identification of adverse events and strengthening adherence to regulations. As an illustration, PubHive Ltd., a UK-based cloud software-as-a-service (SaaS) firm, launched a unified Summary of Product Characteristics (SmPC) management solution in January 2024, designed for life science companies and research entities. This platform unifies essential drug safety data into a singular, readily available repository. It also automates the monitoring of scientific literature and regulatory reporting, fosters improved team cooperation, and optimizes compliance procedures through its cutting-edge AI functionalities. Consequently, pharmacovigilance teams can operate with greater efficiency and foresight, guaranteeing both patient safety and conformity to regulatory requirements.

Who Are The Primary Competitors In The Global Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Post-Marketing Pharmacovigilance And Medical Information Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the post-marketing pharmacovigilance and medical information market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market has experienced swift expansion recently. Its value is set to increase from $6.16 billion in 2024 to $6.90 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has been driven by factors such as the increasing incorporation of AI into pharmacovigilance procedures, a rising need for outsourced drug safety solutions, the escalating complexity of biopharmaceutical goods, an enhanced emphasis on patient-reported outcomes, and strengthened cooperation between regulatory bodies and the industry.

The post-marketing pharmacovigilance and medical information market size is projected for swift expansion in the coming years, with expectations to reach $10.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This expansion during the forecast period stems from several factors, including enhancements in drug safety analytics tools, the increasing uptake of cloud-based pharmacovigilance solutions, the introduction of more novel therapeutics, a heightened focus on proactive risk management approaches, and expanding pharmacovigilance demands within developing economies. Significant tendencies anticipated during this period encompass improvements in automated adverse event detection, the creation of integrated pharmacovigilance platforms, novel approaches to real-time safety data surveillance, better patient engagement instruments for reporting safety concerns, and the evolution of predictive analytics for evaluating drug risks.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Are The Primary Factors Supporting The Post-Marketing Pharmacovigilance And Medical Information Market Expansion?

The increasing occurrence of adverse drug reactions is projected to drive the expansion of the post-marketing pharmacovigilance and medical information market in the future. Adverse drug reactions are defined as detrimental or unexpected consequences arising from medication use at prescribed dosages for purposes such as prevention, diagnosis, or treatment. The frequency of adverse drug reactions is escalating because the growing elderly population frequently necessitates remedies for various chronic illnesses, resulting in concurrent use of numerous medicines, which elevates the potential for detrimental drug interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information aid in addressing adverse drug reactions by identifying, monitoring, and disseminating information about possible side effects once a drug is introduced to the market, thereby assisting in upholding its safety and efficacy. As an illustration, in January 2023, Navikenz, a US-based artificial intelligence-focused IT services company, reported that in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, surpassing the combined fatalities from stroke and diabetes, alongside approximately 2.7 million cases each year leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the increasing occurrence of adverse drug reactions is fueling the expansion of the post-marketing pharmacovigilance and medical information market.

Which Segments Define The Structure Of The Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Product: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

What Strategic Shifts And Innovations Are Influencing The Post-Marketing Pharmacovigilance And Medical Information Market?

Leading entities within the post-marketing pharmacovigilance and medical information market are concentrating on creating sophisticated solutions, such as AI-powered pharmacovigilance workflows, to elevate the precision of adverse event detection and facilitate real-time safety oversight for superior patient results. These AI-powered workflows leverage artificial intelligence to automate drug safety monitoring, allowing for quicker adverse event identification and better adherence to regulations. As an illustration, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, launched a unified Summary of Product Characteristics (SmPC) management system designed for life science firms and research organizations. This platform brings together vital drug safety data into a singular, readily available repository, automates literature surveillance and regulatory submissions, improves team cooperation, and optimizes compliance procedures through advanced AI functionalities. Consequently, pharmacovigilance teams can operate more effectively and preemptively, guaranteeing both patient well-being and conformity to regulatory norms.

Who Are The Primary Market Leaders In The Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

What Regional Factors Are Accelerating Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2025, By The Business Research Company

Drain Cleaning Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Prefabricated Buildings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Medical And Surgical Drainage System Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-and-surgical-drainage-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Post-Marketing Pharmacovigilance And Medical Information Industry By The Forecast Year 2029?

The post-marketing pharmacovigilance and medical information market has experienced significant expansion recently. It is forecast to grow from $6.16 billion in 2024 to $6.90 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.9%. This historical growth can be linked to factors such as the increasing integration of AI in pharmacovigilance processes, a heightened demand for outsourced drug safety services, the rising complexity of biopharmaceutical products, an increasing focus on patient-reported outcomes, and greater collaboration between regulatory agencies and the industry.

The post-marketing pharmacovigilance and medical information market size is projected for substantial expansion in the coming years. This market is anticipated to reach $10.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This projected growth is driven by several factors, including enhanced drug safety analytics tools, a greater uptake of cloud-based pharmacovigilance solutions, an increase in the introduction of new therapeutic products, a heightened focus on proactive risk management approaches, and expanding pharmacovigilance demands in developing regions. Key trends anticipated during this period encompass progress in automated adverse event detection, the creation of integrated pharmacovigilance platforms, breakthroughs in real-time safety data surveillance, improvements in patient engagement instruments for reporting safety information, and the evolution of predictive analytics for evaluating drug risks.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Are The Main Drivers Boosting The Post-Marketing Pharmacovigilance And Medical Information Industry’s Expansion?

The expanding occurrence of adverse drug reactions is projected to fuel the growth of the post-marketing pharmacovigilance and medical information market moving forward. These reactions refer to harmful or unintended effects experienced when a medication is taken at its recommended dosage for prevention, diagnosis, or treatment. The prevalence of adverse drug reactions is increasing due to the aging population’s growing need for treatment of multiple chronic conditions. This often results in the concurrent use of several medications, heightening the probability of adverse drug interactions and unexpected side effects. Post-marketing pharmacovigilance and medical information are essential in managing adverse drug reactions by detecting, tracking, and sharing details about potential side effects after a drug is launched, thereby helping to maintain its safety and effectiveness. A notable example is from January 2023, when Navikenz, a US-based artificial intelligence-focused IT services company, reported that in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, a figure exceeding the combined fatalities from stroke and diabetes. Furthermore, roughly 2.7 million cases each year result in over 100,000 hospitalizations and more than 15,000 deaths. This rising incidence of adverse drug reactions is thus driving the growth of the post-marketing pharmacovigilance and medical information market.

How Is The Post-Marketing Pharmacovigilance And Medical Information Market Segmented?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Product: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Key Trends Are Expected To Influence The Post-Marketing Pharmacovigilance And Medical Information Market In The Coming Years?

Key players within the post-marketing pharmacovigilance and medical information market are primarily focused on developing advanced solutions, such as AI-powered pharmacovigilance workflows, to improve the accuracy of adverse event detection and enable continuous safety monitoring for enhanced patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, thereby accelerating the identification of adverse events and boosting regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, launched a centralized Summary of Product Characteristics (SmPC) management system tailored for life science companies and research organizations. This innovative platform unifies essential drug safety information into one easily accessible location, automates the surveillance of literature and regulatory submissions, strengthens team collaboration, and streamlines compliance processes through its sophisticated AI functionalities. As a result, pharmacovigilance teams can operate more effectively and preemptively, ensuring both patient safety and adherence to regulatory mandates.

Which Global Market Leaders Are Shaping The Future Of The Post-Marketing Pharmacovigilance And Medical Information Sector?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Post-Marketing Pharmacovigilance And Medical Information Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2025, By The Business Research Company

Drain Cleaning Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model